This statistic shows the epidemiology of chronic hepatitis B in eight countries representing the major pharmaceutical markets worldwide in 2014. In these countries combined, the population number aged 18 years and older with chronic hepatitis B was 34.5 million.
Combined epidemiology of chronic hepatitis B in 8 major pharmaceutical markets in 2014*
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Sales for chronic hepatitis B therapeutics 2014 and 2024 by major market
- Basic Statistic Epidemiology of bipolar disorder in 8 major pharma markets 2014
- Premium Statistic Global hip and knee reconstruction market value 2015 vs 2022 by region
- Premium Statistic Forecast of global biosurgery market value 2015 and 2022 by region
- Basic Statistic Bipolar disorder pharma market share in 8 major markets for 2014 & 2024
- Basic Statistic U.S. consumer price index: physician and dental services 1960-2022
- Basic Statistic U.S. specialists and familiarity with biosimilars 2021
- Premium Statistic Number of nurses in Taiwan 2012-2022
- Premium Statistic Number of registered diagnostic radiology specialists in Singapore 2011-2022
- Premium Statistic Percentage of adults with at least one emergency room visit U.S. 2017, by MSA status
About the region
10
- Premium Statistic Pharmaceutical bipolar disorder drug sales 2014 by major market
- Premium Statistic Chronic hepatitis B therapeutic sales share among 8 major markets
- Premium Statistic Global body contouring market share 2015 & 2022 by country
- Premium Statistic Forecast of global point of care diagnostics market value 2015 and 2021 by region
- Basic Statistic Value of select contract pharma manufacturing companies 2022
- Premium Statistic Global point of care diagnostic market revenue 2015 and 2021 by country
- Premium Statistic Enterprise value of top contract pharma research organizations 2022
- Basic Statistic Estimated global per capita health spending 2019 & 2050
- Basic Statistic Main sources of revenue for global mHealth app publishers 2018
- Premium Statistic FDA on breakthrough therapy requests by therapy area 2019
Other regions
10
- Premium Statistic Distribution of new hepatitis C patients in the U.S. by age group 2018
- Basic Statistic Value of the South Korean blood pressure monitor market 2008-2022
- Premium Statistic Value of North American mobility aids and transportation device market 2007-2021
- Basic Statistic Value of North American operating room equipment market 2007-2021, by country
- Premium Statistic Death rate for liver diseases & cirrhosis in Taiwan 2007-2018
- Premium Statistic Share of fatalities in Kuwait by major cause 2019
- Premium Statistic Value of North American patient monitoring accessories market by country 2008-2022
- Premium Statistic Share of fatalities in Saudi Arabia 2019, by major cause
- Premium Statistic Share of fatalities in Qatar by major cause 2019
- Premium Statistic Expenditures on healthcare in the UAE 2011-2027
Related statistics
10
- Premium Statistic Value of North American sterilization equipment market 2007-2021, by country
- Premium Statistic Number of physicians employed in special healthcare in Norway 2012-2021
- Premium Statistic Physician spending as percent total health in each Canadian province 2023
- Basic Statistic Physician spending per capita in Canada by province 2023
- Basic Statistic Provincial/territorial government hospital expenditures in Canada by age 2021
- Premium Statistic Total Canadian other professional's health spending by type and source 2023
- Premium Statistic Hospital spending as percent total health in each Canadian province 2023
- Premium Statistic Hospital spending per capita in Canada by province 2023
- Basic Statistic Value of top home care or hospice providers in the U.S. 2021
- Basic Statistic Percentage of adults with an unmet medical need due to cost U.S. 2017, by MSA status
Further related statistics
10
- Employer firm revenue of residential care and nursing facilities by tax category 2021
- Key figures on established biotech centers worldwide 2012-2016
- Cost savings through urgent care vs emergency department 2012
- Net earnings of UnitedHealth Group 2007-2023
- Medicaid long-term care services expenditures by type of service 1990-21
- Deaths by motor vehicle-related injuries in the U.S. 1930-2022
- Deaths by prostate cancer in the U.S. 1950-2019
- New cases of mumps in the U.S. 1970-2019
- New cases of shigellosis in the U.S. 1950-2019
- Rate of new cases of tuberculosis in the U.S. 1960-2019
Further Content: You might find this interesting as well
Statistics
- Employer firm revenue of residential care and nursing facilities by tax category 2021
- Key figures on established biotech centers worldwide 2012-2016
- Cost savings through urgent care vs emergency department 2012
- Net earnings of UnitedHealth Group 2007-2023
- Medicaid long-term care services expenditures by type of service 1990-21
- Deaths by motor vehicle-related injuries in the U.S. 1930-2022
- Deaths by prostate cancer in the U.S. 1950-2019
- New cases of mumps in the U.S. 1970-2019
- New cases of shigellosis in the U.S. 1950-2019
- Rate of new cases of tuberculosis in the U.S. 1960-2019
GlobalData. (January 1, 2016). Combined epidemiology of chronic hepatitis B in 8 major pharmaceutical markets in 2014* [Graph]. In Statista. Retrieved April 27, 2024, from https://www.statista.com/statistics/648514/epidemiology-of-chronic-hepatitis-b-in-major-pharma-markets/
GlobalData. "Combined epidemiology of chronic hepatitis B in 8 major pharmaceutical markets in 2014*." Chart. January 1, 2016. Statista. Accessed April 27, 2024. https://www.statista.com/statistics/648514/epidemiology-of-chronic-hepatitis-b-in-major-pharma-markets/
GlobalData. (2016). Combined epidemiology of chronic hepatitis B in 8 major pharmaceutical markets in 2014*. Statista. Statista Inc.. Accessed: April 27, 2024. https://www.statista.com/statistics/648514/epidemiology-of-chronic-hepatitis-b-in-major-pharma-markets/
GlobalData. "Combined Epidemiology of Chronic Hepatitis B in 8 Major Pharmaceutical Markets in 2014*." Statista, Statista Inc., 1 Jan 2016, https://www.statista.com/statistics/648514/epidemiology-of-chronic-hepatitis-b-in-major-pharma-markets/
GlobalData, Combined epidemiology of chronic hepatitis B in 8 major pharmaceutical markets in 2014* Statista, https://www.statista.com/statistics/648514/epidemiology-of-chronic-hepatitis-b-in-major-pharma-markets/ (last visited April 27, 2024)
Combined epidemiology of chronic hepatitis B in 8 major pharmaceutical markets in 2014* [Graph], GlobalData, January 1, 2016. [Online]. Available: https://www.statista.com/statistics/648514/epidemiology-of-chronic-hepatitis-b-in-major-pharma-markets/